Sdem Biotechnology

Sdem Biotechnology, officially Beijing Sdem Biotechnology Co., Ltd., is a prominent Chinese contract research organization (CRO) that provides a comprehensive suite of clinical development services to the global and domestic pharmaceutical industries. As a subsidiary of Staidson (Beijing) Biopharmaceuticals, Sdem specializes in clinical trial management for Phase I through IV, regulatory affairs, data management, and biostatistics. The company is well-regarded for its expertise in navigating the complex regulatory landscape of the Chinese National Medical Products Administration (NMPA) for both drugs and medical devices. With headquarters in Beijing and a significant presence in major Chinese cities, Sdem has supported hundreds of clinical trials across diverse therapeutic areas including oncology, cardiology, and infectious diseases. Their integrated service model is designed to accelerate the drug development process while ensuring high-quality, GXP-compliant research outcomes.